• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物发现的计算机模拟药理学:对靶点及其他方面的应用

In silico pharmacology for drug discovery: applications to targets and beyond.

作者信息

Ekins S, Mestres J, Testa B

机构信息

ACT LLC, 1 Penn Plaza, New York, NY 10119, USA.

出版信息

Br J Pharmacol. 2007 Sep;152(1):21-37. doi: 10.1038/sj.bjp.0707306. Epub 2007 Jun 4.

DOI:10.1038/sj.bjp.0707306
PMID:17549046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1978280/
Abstract

Computational (in silico) methods have been developed and widely applied to pharmacology hypothesis development and testing. These in silico methods include databases, quantitative structure-activity relationships, similarity searching, pharmacophores, homology models and other molecular modeling, machine learning, data mining, network analysis tools and data analysis tools that use a computer. Such methods have seen frequent use in the discovery and optimization of novel molecules with affinity to a target, the clarification of absorption, distribution, metabolism, excretion and toxicity properties as well as physicochemical characterization. The first part of this review discussed the methods that have been used for virtual ligand and target-based screening and profiling to predict biological activity. The aim of this second part of the review is to illustrate some of the varied applications of in silico methods for pharmacology in terms of the targets addressed. We will also discuss some of the advantages and disadvantages of in silico methods with respect to in vitro and in vivo methods for pharmacology research. Our conclusion is that the in silico pharmacology paradigm is ongoing and presents a rich array of opportunities that will assist in expediting the discovery of new targets, and ultimately lead to compounds with predicted biological activity for these novel targets.

摘要

计算(计算机模拟)方法已被开发并广泛应用于药理学假设的提出和验证。这些计算机模拟方法包括数据库、定量构效关系、相似性搜索、药效团、同源模型及其他分子模拟、机器学习、数据挖掘、网络分析工具以及使用计算机的数据分析工具。此类方法在发现和优化对靶点具有亲和力的新型分子、阐明吸收、分布、代谢、排泄和毒性特性以及物理化学表征方面经常被使用。本综述的第一部分讨论了用于虚拟配体和基于靶点的筛选及分析以预测生物活性的方法。本综述第二部分的目的是根据所涉及的靶点阐述计算机模拟方法在药理学中的一些不同应用。我们还将讨论计算机模拟方法相对于药理学研究的体外和体内方法的一些优缺点。我们的结论是,计算机模拟药理学范式仍在发展,并且提供了丰富的机会,将有助于加速新靶点的发现,并最终得到针对这些新靶点具有预测生物活性的化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/de580e8f8b6a/0707306f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/f9929c382e2f/0707306f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/b1945871d10d/0707306f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/de580e8f8b6a/0707306f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/f9929c382e2f/0707306f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/b1945871d10d/0707306f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/1978280/de580e8f8b6a/0707306f3.jpg

相似文献

1
In silico pharmacology for drug discovery: applications to targets and beyond.用于药物发现的计算机模拟药理学:对靶点及其他方面的应用
Br J Pharmacol. 2007 Sep;152(1):21-37. doi: 10.1038/sj.bjp.0707306. Epub 2007 Jun 4.
2
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.用于药物发现的计算机模拟药理学:虚拟配体筛选和分析方法
Br J Pharmacol. 2007 Sep;152(1):9-20. doi: 10.1038/sj.bjp.0707305. Epub 2007 Jun 4.
3
Chemogenomic approaches to drug discovery: similar receptors bind similar ligands.用于药物发现的化学基因组学方法:相似的受体结合相似的配体。
Br J Pharmacol. 2007 Sep;152(1):5-7. doi: 10.1038/sj.bjp.0707308. Epub 2007 May 29.
4
From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.从药物靶点到先导化合物——勾勒计算机辅助先导分子设计的物理化学途径
Curr Pharm Des. 2007;13(34):3454-70. doi: 10.2174/138161207782794220.
5
Chemogenomic approaches to rational drug design.用于合理药物设计的化学基因组学方法。
Br J Pharmacol. 2007 Sep;152(1):38-52. doi: 10.1038/sj.bjp.0707307. Epub 2007 May 29.
6
Systems Pharmacology in Small Molecular Drug Discovery.系统药理学在小分子药物发现中的应用。
Int J Mol Sci. 2016 Feb 18;17(2):246. doi: 10.3390/ijms17020246.
7
TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.TargetHunter:一种基于化学生物基因组数据库的计算机辅助药物靶点预测工具,用于预测小分子药物的治疗潜力。
AAPS J. 2013 Apr;15(2):395-406. doi: 10.1208/s12248-012-9449-z. Epub 2013 Jan 5.
8
The importance of discerning shape in molecular pharmacology.辨别形状在分子药理学中的重要性。
Trends Pharmacol Sci. 2009 Mar;30(3):138-47. doi: 10.1016/j.tips.2008.12.001. Epub 2009 Jan 31.
9
Application of in silico approaches to predicting drug--drug interactions.计算机模拟方法在预测药物-药物相互作用中的应用。
J Pharmacol Toxicol Methods. 2001 Jan-Feb;45(1):65-9. doi: 10.1016/s1056-8719(01)00119-8.
10
Free resources to assist structure-based virtual ligand screening experiments.用于辅助基于结构的虚拟配体筛选实验的免费资源。
Curr Protein Pept Sci. 2007 Aug;8(4):381-411. doi: 10.2174/138920307781369391.

引用本文的文献

1
Network pharmacology-based approach to research the effects and mechanisms of injection against idiopathic pulmonary fibrosis.基于网络药理学的方法研究注射剂治疗特发性肺纤维化的作用及机制
Front Med (Lausanne). 2025 Jun 24;12:1569590. doi: 10.3389/fmed.2025.1569590. eCollection 2025.
2
Cracking the code: the clinical and molecular impact of aminopyridines; a review (2019-2024).破解密码:氨基吡啶的临床与分子影响;综述(2019 - 2024年)
RSC Adv. 2025 Jan 8;15(1):688-711. doi: 10.1039/d4ra07438f. eCollection 2025 Jan 2.
3
Evaluating the Anticancer Properties of Novel Piscidinol A Derivatives: Insights from DFT, Molecular Docking, and Molecular Dynamics Studies.

本文引用的文献

1
The diversity challenge in combinatorial chemistry.组合化学中的多样性挑战。
Curr Opin Drug Discov Devel. 1998 Jul;1(1):66-70.
2
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.用于药物发现的计算机模拟药理学:虚拟配体筛选和分析方法
Br J Pharmacol. 2007 Sep;152(1):9-20. doi: 10.1038/sj.bjp.0707305. Epub 2007 Jun 4.
3
The biochemistry of drug metabolism--an introduction: part 1. Principles and overview.药物代谢的生物化学——引言:第1部分。原理与概述。
评估新型鱼抗菌肽A衍生物的抗癌特性:来自密度泛函理论、分子对接和分子动力学研究的见解
ACS Omega. 2024 Nov 29;9(50):49639-49661. doi: 10.1021/acsomega.4c07808. eCollection 2024 Dec 17.
4
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites.用于肠道微生物群产生的格列齐特代谢物药理特性预评估的计算研究。
Front Pharmacol. 2024 Dec 3;15:1492284. doi: 10.3389/fphar.2024.1492284. eCollection 2024.
5
Insights into L. Ethanol Extract: Cytotoxic Effects, LC-ESI-QTOF-MS/MS Chemical Profiling, Molecular Docking, and Acute Toxicity Study.L.乙醇提取物的深入研究:细胞毒性作用、液相色谱-电喷雾电离-四极杆飞行时间串联质谱化学剖析、分子对接及急性毒性研究。
Pharmaceuticals (Basel). 2024 Oct 9;17(10):1347. doi: 10.3390/ph17101347.
6
Assessing the cytotoxicity of phenolic and terpene fractions extracted from Iraqi  against AMJ13 and SK-GT-4 human cancer cell lines.评估从伊拉克提取的酚类和萜烯类化合物对 AMJ13 和 SK-GT-4 人癌细胞系的细胞毒性。
F1000Res. 2024 Sep 10;12:433. doi: 10.12688/f1000research.131336.3. eCollection 2023.
7
Molecular docking and antimicrobial activities of photoexcited inhibitors in antimicrobial photodynamic therapy against Enterococcus faecalis biofilms in endodontic infections.光激发抑制剂在牙髓感染中针对粪肠球菌生物膜的抗菌光动力疗法中的分子对接及抗菌活性
AMB Express. 2024 Aug 31;14(1):94. doi: 10.1186/s13568-024-01751-y.
8
The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications.金发姑娘范式:比较经典机器学习、大语言模型和少样本学习在药物发现应用中的表现
Commun Chem. 2024 Jun 12;7(1):134. doi: 10.1038/s42004-024-01220-4.
9
Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from sp.: An In Silico Approach.探索来自[具体植物名称]的7α-乙酰氧基-6β-羟基肉叶烯酮半合成衍生物的抗癌潜力:一种计算机模拟方法。
Int J Mol Sci. 2024 Apr 20;25(8):4529. doi: 10.3390/ijms25084529.
10
New thiazole, thiophene and 2-pyridone compounds incorporating dimethylaniline moiety: synthesis, cytotoxicity, ADME and molecular docking studies.含二甲基苯胺部分的新型噻唑、噻吩和2-吡啶酮化合物:合成、细胞毒性、药物代谢动力学及分子对接研究
BMC Chem. 2024 Mar 14;18(1):52. doi: 10.1186/s13065-024-01136-z.
Chem Biodivers. 2006 Oct;3(10):1053-101. doi: 10.1002/cbdv.200690111.
4
Orphan nuclear receptors, excellent targets of drug discovery.孤儿核受体,药物研发的优质靶点。
Comb Chem High Throughput Screen. 2006 Nov;9(9):683-9. doi: 10.2174/138620706778700125.
5
Pharmacophore-based discovery of ligands for drug transporters.基于药效团的药物转运体配体发现
Adv Drug Deliv Rev. 2006 Nov 30;58(12-13):1431-50. doi: 10.1016/j.addr.2006.09.006. Epub 2006 Sep 26.
6
Rapid identification of P-glycoprotein substrates and inhibitors.P-糖蛋白底物和抑制剂的快速鉴定。
Drug Metab Dispos. 2006 Dec;34(12):1976-84. doi: 10.1124/dmd.106.012351. Epub 2006 Sep 22.
7
QSAR modeling of in vitro inhibition of cytochrome P450 3A4.细胞色素P450 3A4体外抑制作用的定量构效关系建模
J Chem Inf Model. 2006 Sep-Oct;46(5):2125-34. doi: 10.1021/ci0600915.
8
Introducing the consensus modeling concept in genetic algorithms: application to interpretable discriminant analysis.遗传算法中的共识建模概念介绍:在可解释判别分析中的应用。
J Chem Inf Model. 2006 Sep-Oct;46(5):2110-24. doi: 10.1021/ci050529l.
9
A preliminary in silico lead series of 2-phthalimidinoglutaric acid analogues designed as MMP-3 inhibitors.设计为基质金属蛋白酶-3抑制剂的2-邻苯二甲酰亚氨基戊二酸类似物的初步计算机辅助先导系列。
J Chem Inf Model. 2006 Sep-Oct;46(5):2104-9. doi: 10.1021/ci0601362.
10
Structural basis for ligand promiscuity in cytochrome P450 3A4.细胞色素P450 3A4中配体混杂性的结构基础。
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13682-7. doi: 10.1073/pnas.0603236103. Epub 2006 Sep 5.